DRW Securities’s Allarity Therapeutics ALLR Stock Holding History

DRW Securities’s Portfolio ALLR Stock Details ALLR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-122,741	Closed	-$133K	–	1249
2025 Q4	$133K	Buy	+122,741	New	+$156K	﹤0.01%	1028

Other funds holding ALLR

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

DRW Securities's ALLR Position: Q1 2026 in Review

DRW Securities sold out of Allarity Therapeutics (ALLR) in Q1 2026, closing a stake of 122,741 shares — an estimated $133K sold.

DRW Securities first reported a position in ALLR in Q4 2025 and held it in 1 quarter. The position peaked at $133K in Q4 2025. 14 funds tracked by Wall St. Rank hold ALLR as of Q1 2026.

DRW Securities reported no remaining Allarity Therapeutics position as of Q1 2026 after selling out during the quarter.
DRW Securities sold 122,741 Allarity Therapeutics shares in Q1 2026, an estimated $133K.
DRW Securities first reported a position in Allarity Therapeutics in Q4 2025 and held it in 1 quarter.
DRW Securities's Allarity Therapeutics position peaked at $133K in Q4 2025.
14 funds tracked by Wall St. Rank held Allarity Therapeutics as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.